GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study

Autor:	Bonifazi, Francesca, Solano, Carlos, Wolschke, Christine, Sessa, Mariarosaria, Patriarca, Francesca, Zallio, Francesco, Nagler, Arnon, Selleri, Carmine, Risitano, Antonio Maria, Messina, Giuseppe, Bethge, Wolfgang, Herrera, Pilar, Sureda, Anna, Carella, Angelo Michele, Cimminiello, Michele, Guidi, Stefano, Finke, Jürgen, Sorasio, Roberto, Ferra, Christelle, Sierra, Jorge, Russo, Domenico, Benedetti, Edoardo, Milone, Giuseppe, Benedetti, Fabio, Heinzelmann, Marion, Pastore, Domenico, Jurado, Manuel, Terruzzi, Elisabetta, Narni, Franco, Völp, Andreas, Ayuk, Francis, Ruutu, Tapani, Kröger, Nicolaus
Zdroj:	In The Lancet Haematology February 2019 6(2):e89-e99
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu